FREE GLP-1 membership for 12 months*
Now with oral GLP-1s!
At-home blood testing at 0, 6, & 12 months
Best prices on FDA-Approved GLP-1s
Common side-effect care pack included
*Terms and conditions apply
*Terms and conditions apply
FDA approved
Shown results of up to 15% weight loss
Injection-free – just one pill a day
Includes the same weight loss ingredients as the injection pen (semaglutide)
.png)
GLP-1 treatments have been shown to reduce HbA1c by up to ~1.0–1.5 percentage points in clinical trials.
Source: Jastreboff et al., NEJM 2022; Pratley et al., Lancet 2018
GLP-1 medications have demonstrated improvements in LDL cholesterol and triglycerides compared with placebo.
Source: Nauck & Meier, Lancet Diabetes Endocrinol 2019
Studies show GLP-1 therapy can lead to significant reductions in CRP, a key marker of inflammation.
Source: Hattori et al., Cardiovascular Diabetology 2020
Research shows GLP-1 therapy can reduce liver fat content and improve ALT in people with metabolic dysfunction.
Source: Armstrong et al., Lancet 2016
In long-term studies, GLP-1 receptor agonists have been associated with reduced risk of major cardiovascular events in people with elevated cardiometabolic risk.
Source: Marso et al., NEJM 2016 (LEADER Trial)
